These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 16691623

  • 1. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G, Longhi A, Cesari M, Versari M, Bertoni F.
    Cancer; 2006 Jun 15; 106(12):2701-6. PubMed ID: 16691623
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P.
    Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923
    [Abstract] [Full Text] [Related]

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 4. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
    Crompton BD, Goldsby RE, Weinberg VK, Feren R, O'Donnell RJ, Ablin AR.
    Pediatr Blood Cancer; 2006 Sep 15; 47(3):255-9. PubMed ID: 16123980
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P.
    Eur J Cancer; 2005 Dec 15; 41(18):2836-45. PubMed ID: 16298125
    [Abstract] [Full Text] [Related]

  • 6. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G, Longhi A, Bertoni F, Briccoli A, Versari M, Pignotti E, Picci P.
    Acta Orthop; 2006 Dec 15; 77(6):938-43. PubMed ID: 17260205
    [Abstract] [Full Text] [Related]

  • 7. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 8. Management and outcome after local recurrence of osteosarcoma.
    Grimer RJ, Sommerville S, Warnock D, Carter S, Tillman R, Abudu A, Spooner D.
    Eur J Cancer; 2005 Mar 15; 41(4):578-83. PubMed ID: 15737563
    [Abstract] [Full Text] [Related]

  • 9. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G, Longhi A, Ferrari S, Mercuri M, Barbieri E, Bertoni F, Bacchini P, Picci P.
    Eur J Surg Oncol; 2006 Nov 15; 32(9):974-9. PubMed ID: 16621429
    [Abstract] [Full Text] [Related]

  • 10. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS, Arndt CA.
    Cancer; 2003 Dec 01; 98(11):2447-56. PubMed ID: 14635080
    [Abstract] [Full Text] [Related]

  • 11. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K.
    J Clin Oncol; 2005 Jan 20; 23(3):559-68. PubMed ID: 15659502
    [Abstract] [Full Text] [Related]

  • 12. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH.
    Cancer; 2006 Oct 01; 107(7):1607-16. PubMed ID: 16933325
    [Abstract] [Full Text] [Related]

  • 13. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O.
    Cancer; 2005 Sep 01; 104(5):1100-9. PubMed ID: 16015627
    [Abstract] [Full Text] [Related]

  • 14. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT, Blakely ML, Jaffe N, Cox CS, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ, Lally KP.
    J Pediatr Surg; 2006 Jan 01; 41(1):194-9. PubMed ID: 16410132
    [Abstract] [Full Text] [Related]

  • 15. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S, Shin SJ, Jung M, Jeong J, Lee YJ, Shin KH, Roh JK, Rha SY.
    Oncology; 2011 Jan 01; 80(1-2):107-17. PubMed ID: 21677455
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q, Niu XH, Cai YB, Hao L, Ding Y.
    Zhonghua Wai Ke Za Zhi; 2007 Aug 15; 45(16):1114-7. PubMed ID: 18005614
    [Abstract] [Full Text] [Related]

  • 17. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G, Briccoli A, Longhi A, Ferrari S, Mercuri M, Faggioli F, Versari M, Picci P.
    Acta Oncol; 2005 Aug 15; 44(7):748-55. PubMed ID: 16227167
    [Abstract] [Full Text] [Related]

  • 18. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, Versari M, Picci P.
    Eur J Cancer; 2005 Sep 15; 41(14):2079-85. PubMed ID: 16115755
    [Abstract] [Full Text] [Related]

  • 19. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G, Ferrari S, Ruggieri P, Biagini R, Fabbri N, Campanacci L, Bacchini P, Longhi A, Forni C, Bertoni F.
    Acta Orthop Scand; 2001 Apr 15; 72(2):167-72. PubMed ID: 11372948
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):505-11. PubMed ID: 17118571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.